Pavelka, Karel
Akkoç, Nurullah
Al-Maini, Mustafa
Zerbini, Cristiano A. F.
Karateev, Dmitry E.
Nasonov, Evgeny L.
Rahman, Mahboob U.
Pedersen, Ronald
Dinh, Andrew
Shen, Qi
Vasilescu, Radu
Kotak, Sameer
Mahgoub, Ehab
Vlahos, Bonnie http://orcid.org/0000-0002-8385-7493
Funding for this research was provided by:
Pfizer
Article History
Received: 27 October 2016
Accepted: 18 May 2017
First Online: 9 June 2017
Compliance with ethical standards
:
: Karel Pavelka has received honoraria for lectures and consultancies from Amgen, AbbVie, Roche, Bristol-Myers Squibb (BMS), Merck Sharp & Dohme (MSD), and Pfizer. Nurullah Akkoç has received honoraria from and is an advisory board member for Pfizer, AbbVie, MSD, UCB, Novartis, and Amgen; research funding from Pfizer and UCB; and other grants from MSD. Cristiano Zerbini has received research grants from Novartis, Pfizer, BMS, Lilly, Amgen, Sanofi, and MSD; consulting fees from Pfizer, BMS, Lilly, and MSD; and is an advisory board member for Pfizer, Lilly, and Sanofi. Dmitry E. Karateev has received consulting and speakers’ bureau fees from AbbVie, BMS, Egis, Medac, MSD, Novartis, Pfizer, and Roche. Mustafa Al-Maini and Evgeny L. Nasonov declare no conflicts of interest. Mahboob Rahman was an employee of Pfizer during the conception/conduct of the study and owns Pfizer stock. Ron Pedersen, Andrew Dinh, Qi Shen, Radu Vasilescu, Sameer Kotak, Ehab Mahgoub, and Bonnie Vlahos are employees of Pfizer and Pfizer stockholders.
: This study was funded by Pfizer. Editorial/medical writing support was provided by Donna McGuire of Engage Scientific Solutions and was funded by Pfizer.